One-Year Serum Albumin is an Independent Predictor of Outcomes in Kidney Transplant Recipients
Rebecca M. Dahlberg(University of Wisconsin–Madison), Arjang Djamali(MaineHealth), Brenda Muth(University of Wisconsin–Madison), Robert Hofmann, Milagros Samaniego(Henry Ford Health System), John D. Pirsch(University of Wisconsin–Madison)
Cited by 25
Related Papers
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study
|American Journal of Transplantation|2003|380
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients
|Antimicrobial Agents and Chemotherapy|2000|363
Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
|American Journal of Transplantation|2004|283
Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2015|193